Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev<sup>®</sup>), a bevacizumab biosimilar, under extended in-use conditions.

J Oncol Pharm Pract · 2023 · PMC10302395 · PMID 35312402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, none of the samples showed a trend in terms of the increase and/or decrease in the abundance of either species ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.